Overview

Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This retrospective study aims to assess the economic impact of early initiation of 5-alpha-reductase inhibitor (5ARI) therapy in patients with enlarged prostate (EP) receiving 5ARI and alpha-blocker (AB) combination therapy. Both the Integrated Health Care Information Solutions and PharMetrics databases will be utilized for this study (2000-2007).
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
5-alpha Reductase Inhibitors
Dutasteride